NuVasive, Inc. (NASDAQ:NUVA) Released Its 1st Quarter Earnings (Recap)

Experts Expectations vs Actual:

The company reported adjusted net income of 20 cents per share. The company crushes the estimate of 7 cents per share. NUVA crush the average revenue estimate of $143.6 million.

NuVasive, Inc. vs Industry Leaders:

The company is ranked 43^rd among 204 Medical Appliances & Equipment Companies by market capitalization. The company maintains the ranked 9^th PEG ratio of 2.28 percent 44^th among its competitors. NUVA maintains the ranked 56^th long term growth rate among its industry peers which stands at 9.67 percent. The company maintains the ranked 68^th Revenue Growth rate of 16.20 percent in its industry.

1^st Quarter 2012 Financial Results:

Revenue:

NuVasive, Inc. (NASDAQ:NUVA) reported the revenue of $151.69 million for the quarter ended March 31^st, 2012 as compared to revenue of 124.47 million for the same period last year.

Net Income 2012 vs Net Income 2011:

NuVasive, Inc. (NASDAQ:NUVA) reported the net  profit  of $0.67 million or earnings of $0.03 per share for the respective quarter as compared to net income of $2.36 million or earnings of $0.10 per share last year.

Balance Sheet:

The company’s total assets accumulate up to $1.14 billion with highest proportion of current assets in its composition. The company maintains strong short term liquidity position as per its current ratio of 2.85 times. Its total liabilities stand at $639.59 million as compared to its total equity of 509.55 million.

NuVasive, Inc.’s Competitors:

Alphatec Holdings, Inc. (NASDAQ:ATEC), Stryker Corporation (NYSE:SYK), Zimmer Holdings, Inc. (NYSE:ZMH), TranS1 Inc. (NASDAQ:TSON), Orthofix International NV (NASDAQ:OFIX), Medtronic, Inc. (NYSE:MDT), Exactech, Inc. (NASDAQ:EXAC), Wright Medical Group, Inc. (NASDAQ:WMGI), Orthovita, Inc. (NASDAQ:VITA), and RTI Biologics Inc. (NASDAQ:RTIX).